['Sex hormone concentrations', 'patients', 'rheumatoid arthritis', '12 weeks', 'anti-tumor necrosis factor therapy', 'OBJECTIVE', 'Androgens', 'dehydroepiandrosterone sulfate', 'DHEAS', 'testosterone', 'postmenopausal women', 'rheumatoid arthritis', 'RA', 'controls', 'contrast', 'controls', 'serum levels', 'estrogens', 'women', 'RA', 'tumor necrosis factor', '(TNF) alters production', 'these hormones', 'we', 'changes', 'these hormones', 'anti-TNF antibody (anti-TNF) therapy', 'adalimumab', 'longstanding RA', 'METHODS', 'this longitudinal anti-TNF therapy study', '13 patients', 'long-standing RA', 'prior prednisolone', '7 infusions', 'anti-TNF', 'we', 'serum concentrations', 'interleukin', 'androstenedione', 'DHEA', 'DHEAS', 'free testosterone', 'estrone', '17ss-estradiol', 'Levels', 'these hormones', 'patients', 'serum levels', '31 age', 'sex', 'healthy controls', 'RESULTS', 'treatment', 'anti-TNF', 'an impressive decrease', 'clinical markers', 'inflammation', 'erythrocyte sedimentation rate', 'serum levels', 'Serum levels', 'DHEAS', 'free testosterone', 'baseline', 'patients', 'controls', 'anti-TNF therapy', 'Serum levels', 'DHEA', '17ss-estradiol', 'patients', 'controls', 'anti-TNF therapy', 'initially increased levels', 'Molar ratios', 'hormones', 'hormone shifts', 'converting', 'enzymes', 'typical alterations', 'baseline', 'anti-TNF therapy', 'CONCLUSION', 'Longterm therapy', 'anti-TNF', 'altered serum levels', 'typical sex hormones', 'patients', 'RA', 'baseline values', 'patients', 'RA', 'alterations', 'sex hormones', 'altered activity', 'respective converting enzymes', 'a long-lasting period', 'at least 12 weeks', 'Control', 'hepatic glycogen metabolism', 'the rhesus monkey', 'effect', 'glucose', 'insulin', 'glucagon administration', 'The effects', 'intravenous glucose', 'insulin', 'glucagon', 'admininistration', 'the hepatic glycogen synthase', 'glycogen phosphorylase systems', 'the anesthetized rhesus monkey', 'Results', 'measurements', 'hepatic cyclic AMP (cAMP) concentrations', 'plasma glucose', 'insulin', 'glucagon concentrations', 'Both glucose', 'insulin administration', 'significant inactivation', 'phosphorylase', '1 min', 'more gradual activation', 'synthase', 'Neither glucose', 'insulin', 'significant changes', 'hepatic cAMP', 'Marked hyperglucagonemia', 'insulin-induced hypoglycemia', 'increases', 'hepatic cAMP', 'the elevated insulin levels', 'glucagon action', 'the hepatic adenylate cyclase-cAMP system', 'Glucagon administration', 'large increases', 'hepatic cAMP', 'activation', 'phosphorylase', '1 min', 'more gradual inactivation', 'synthase', 'it', 'glucose', 'Concomitant glucose infusion', 'increased plasma insulin concentrations', 'the duration', 'hepatic cAMP elevations', 'glucagon adminstration', 'an insulin inhibition', 'glucagon action', 'the hepatic adenylate-cAMP system']
